OCRX

Ocera Therapeutics, Inc.
OCRX

Overview Fund Activity
Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

33 hedge funds and large institutions have $14.7M invested in Ocera Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
–
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
6
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
1
Deerfield Management
New York
$1.09M
2
BCM
2
Bridgeway Capital Management
Texas
$401K
3
SM
3
Sabby Management
Florida
$806K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$321K
5
BFA
5
BlackRock Fund Advisors
California
$88K

Top Sellers

1
TI
1
Turner Investments
Pennsylvania
$265K
2
SFM
2
Sphera Funds Management
Israel
$0
3
WMSA
3
Weiss Multi-Strategy Advisers
New York
$215K
4
ECM
4
Endurant Capital Management
California
$196K
5
VKH
5
Virtu KCG Holdings
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BIM
26
BlackRock Investment Management
Delaware
$5K – – –
Morgan Stanley
27
Morgan Stanley
New York
$3K – – –
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K – – –
UBS Group
29
UBS Group
Switzerland
$2K +$2K +1,040 New
TRCT
30
Tower Research Capital (TRC)
New York
$1K -$490 -168 -33%
SFM
31
Sphera Funds Management
Israel
– -$549K -186,800 Closed
VKH
32
Virtu KCG Holdings
New York
– -$39K -13,382 Closed
Group One Trading
33
Group One Trading
Illinois
– -$12K -4,154 Closed
1
2